Zoom Webinar, 1:00 to 2:00 PM PT, Thursday, May 13
https://www.youtube.com/watch?v=IeHIjqbjXXc
The cost of healthcare drives stakeholder interest in reimbursement. Before investors risk their money, they want to know about coverage, coding, and payment. Payers expect better outcomes at equal or lower cost. Hospitals are establishing value analysis committees. Physicians want products that help them meet metrics. And patients are becoming more educated and prefer interventions that improve quality of life at the lowest cost.
Until recently the main focus for health technology companies was FDA clearance. That is still important, but reimbursement is now a top concern. Join this session to learn the basics of reimbursement and how you can develop an integrated clinical plan.
Zoom Webinar Thursday, October 22, Noon to 1:00 PM PST
Startup founders put years of blood, sweat, and tears into their companies, often with the end goal of strategic acquisition. All their work may be in vain, though, if they have not thought and planned in advance about the strategic needs of the acquirer. Understanding how strategics do their due diligence, the key areas/metrics they look for to make the acquisition and the areas they will be interested in when your technology is ripe for acquisition.
What should YOU be thinking about?
Join us to learn from Holly Sheffield, president of CooperSurgical, a leading medtech company that has acquired more than 13 companies in the past 5 years. Prior to joining CooperSurgical, Ms. Sheffield had a 20+ year career as an investment banker, advising companies on strategic acquisitions.
Speaker: Dave Jackson, Founder & CTO, Green Mars Consulting
Zoom Webinar Tuesday, September 29, 2:00 to 3:00 PM PST
The cloud is ubiquitous; everyone needs it, everyone uses it. But to use it right and use it well for business, there are some core considerations: How do you build software in the cloud that will scale? How do you built it to be secure? How do you manage a large user base across a set of very different services? The list of considerations grows when you look more specifically at healthcare in the cloud. Then you also have to think about patient data anonymization, regulatory issues, medical-specific domain technologies in the cloud, performance, and availability to meet the demands of patient care.
In a crisis, how do you lead an early-stage company? How do you manage runway and keep morale up, continuing to deliver important work necessary to advance? Two experienced serial entrepreneurs, and the investors who backed them, will get together to share their wisdom. Matt Likens, now CEO of GT Medical, led Ulthera through the 2008 crisis to acquisition six years later. Adam Berman, who now leads Alleviant, launched TVA Medical in 2008 and took it to acquisition in 2018. Justin Klein of Vensana Capital invested in Ulthera under Matt; James Eadie of Santé Ventures invested in TVA under Adam. Join us on Wednesday, June 24 to learn from their past and current experiences.
While new guidelines like social distancing and shelter-in-place affect the average person’s day-to-day experience during the pandemic, temporary changes to coverage and payment rules for health care providers affect theirs. Marc Samuels is Founder & CEO of ADVI Health, a healthcare consulting company that has worked with 19 of the top 25 medtech companies in the world. In this discussion, Marc and ADVI Senior Associate Micaela Laber will explore recent administrative and legislative policy changes in response to the COVID-19 Public Health Emergency and their implications for the present and future of health care. Key topics covered include telehealth, remote monitoring, hospitals without walls, home infusion, and state waivers across Medicare, Medicaid, and commercial payers.
Norwich Ventures, of which Aaron Sandoski is co-founder & managing director, recently closed the $90 million Medtech Convergence Fund. The firm intends to invest the fund in startups whose technologies embody the convergence of AI, data, or telehealth with traditional engineering. The pandemic, however, has changed the outlook for everyone, including VCs. Join this webinar to learn about Norwich’s approach to investing in the current climate.
Ali Farahanchi is Managing Director at DHVC, an early-stage tech and life science fund in Palo Alto. With more than $650M assets under management and 100+ companies in its portfolio, DHVC invests in variety of areas in healthcare including therapeutics, diagnostics and tools, and digital health, with strong emphasis on novel mechanisms and data-driven platforms. Previously Ali has worked in research and in consulting roles in semiconductor and healthcare industries, and has obtained graduate degrees in engineering and management from MIT and University of Chicago.
On March 27, 2020, President Trump signed the Coronavirus Aid, Relief, and Economic Security Act into law, also known as the “CARES Act”. The CARES Act is a wide ranging stimulus bill in response to the COVID-19 outbreak. Title I of the CARES Act (“Keeping American Workers Paid and Employed Act”) provides for the expansion of the Small Business Act (SBA) in order to create a new line of federally-guaranteed small business loans (“Program Loans”) available for the period of February 15, 2020 to June 30, 2020. These Program Loans are available to small businesses with fewer than 500 employees (see below for more detailed information) and permit such qualified small businesses to borrow up to 2.5 times the average total monthly payroll costs incurred in the one-year period before the Program Loan is made with a cap of $10 million. Program Loans do not require any collateral, have a deferred payment period of six months to one year and are eligible for loan forgiveness for certain categories of spending during the eight-week period following the issuance of the loan. View CARES Act summary
Join us to learn about the CARES Act and find out how your organization can get support. Q&A welcome.
To ensure a successful sale of your startup you need to start planning early. Several issues are key. Among them: how to maximize value; how to manage stakeholders; and how to close the deal, which is everything once you decide to sell. To learn how to do it right—as well as hard-learned lessons about what happens if you don’t—join us on Thursday, February 20 to hear from Sam Williams, a partner in corporate law at the firm Brown Rudnick.
Tak joined NEA in 2018 as a Principal on the healthcare team. He focuses on medical device investments.
Prior to NEA, Tak was a Venture Partner at Merieux Development Venture Fund where he led all phases of investment for healthcare startups, including sourcing, diligence and investment approvals. Tak also co-founded Lexington Medical, a commercial-stage medical device startup in the gastrointestinal surgery space. Prior to Merieux and Lexington, Tak was VP of Business Development for the Global Surgical Division at Bausch & Lomb, and was responsible for all business development efforts in the ophthalmic surgical division. Tak has held various corporate and business development leadership roles at Edwards Lifesciences in the Heart Valve Therapy Division and Advanced Medical Optics (acquired by Johnson & Johnson).
Tak received a BS with Honors in Engineering and Applied Science from the California Institute of Technology, an MD from the University of California, Irvine, and an MBA from Harvard Business School.
